Providing health care, education and resources around the world, wherever they are needed most.
Category Image
Why Pathogen Surveillance Is Critical During a “Tripledemic”
The 2022–23 “tripledemic” season—in which influenza, SARS-CoV-2, and respiratory syncytial virus (RSV) all surged at the same time—was especially bad for Arizona, says Efrem Lim, an Arizona State University (ASU) virologist with the Center for Fundamental and Applied Microbiomics
Virus Hunt Zooms In To Focus on New Potential Pandemics
Members of the Abbott Pandemic Defense Coalition have recently contributed to two studies that involve the scrutinization of a virus to establish whether it has the potential to become an outbreak.
Cummins Plant Begins Building Prototype of Fuel Agnostic Engines To Prepare for Production
After building its 5 millionth engine, Cummins Inc.’s Rocky Mount Engine Plant (RMEP) in North Carolina is continuing its long history of innovation in engine technology and manufacturing. The next stop? Building fuel-agnostic engines in its VPI Lab.
Americares and Quest Diagnostics Expand Collaboration to Support Health Equity
Americares and Quest Diagnostics, with the Quest Diagnostics Foundation, are teaming up to provide no-cost diagnostic services and expanded telehealth services to free and charitable clinics across the United States to reduce health disparities in underserved communities.
Insights From Dublin: Fostering Precision Oncology for Better Patient Outcomes
The 35th European Congress of Pathology (ECP), taking place September 9–13 in Dublin, Ireland, is a focal point for pathologists from over 100 countries and serves as a platform for the latest advancements in the field.
Farm-To-Fork Approach To Boost UK’s Nature-Positive Net Zero Transition
There is no denying the fact we are all climate influencers in some way and how we purchase, cook and eat food has an immense impact on the planet.
Viatris Announces U.S. FDA Tentative Approval of a Paediatric Formulation of Abacavir (ABC)/Dolutegravir (DTG)/Lamivudine (3TC), a Once-Daily Treatment for Children Living With HIV
Viatris Inc. today announced U.S. Food and Drug Administration (FDA) tentative approval for a New Drug Application for abacavir 60 mg/dolutegravir 5 mg/lamivudine 30 mg tablets for oral suspension for the treatment of HIV-1 infection in paediatric patients.
Gilead Sciences: Fifth Anniversary of COMPASS: Helping Address the HIV Epidemic in the U.S. South
This year marks the fifth anniversary of the Gilead COMPASS Initiative®, a 10-year, more than $100 million commitment to addressing the HIV epidemic in the Southern United States.
Direct Relief and The Pfizer Foundation Support 19 Programs To Improve Infectious Disease Care in the United States
Direct Relief today announced the recipients of the Innovation Awards in Community Health: Addressing Infectious Disease in Underserved Communities. Grants totaling more than $4.5 million will go to 19 U.S. safety-net community healthcare providers
Direct Relief Delivers $1 Billion in Donated Medicine and Medical Supplies to Ukraine
In response to the brutal fighting, continuing attacks on Ukraine’s civilians, destruction of the country’s electricity infrastructure, and infliction of widespread psychological trauma, Direct Relief has conducted its largest and most sustained humanitarian aid response